Nutrition Support Consultant features issues pertinent to the clinical aspects of pharmacy nutritional support practice.
Get full access to this article
View all access options for this article.
References
1.
StreatS.J., BeddoeA.H., HillG.L.Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma.1987; 27: 262–6.
2.
ShawJ.H., WildboreM., WolfeR.R.Whole body protein kinetics in severely septic patients. The response to glucose infusion and total parenteral nutrition. Ann Surg.1987; 205: 288–94.
3.
TakalaJ., RuokonenE., WebsterN.R.Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med.1999; 341: 785–92.
4.
GervasioJ.M., DickersonR.N., SwearingenJ.Oxandrolone in trauma patients. Pharmacotherapy.2000; 20: 1328–34.
5.
HausmannD.F., NutzV., RommelsheimK.Anabolic steroids in polytrauma patients. Influence on renal nitrogen and amino acid losses: A double-blind study. JPEN J Parenter Enteral Nutr.1990; 14: 111–4.
6.
MosebachK.O., HausmannD., Cas-pariR.Deca-Durabolin and parenteral nutrition in post-traumatic patients. Acta Endocrinol Suppl.1985; 271: 60–9.
7.
DemlingR.H., SeigneP.Metabolic management of patients with severe burns. World J Surg.2000; 24: 673–80.
8.
DemlingR.H.Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns.1999; 25: 215–21.
9.
DemlingR., De SantiL.Closure of the “non-healing wound” corresponds with correction of weight loss using the anabolic agent oxandrolone. Ostomy Wound Manag.1998; 44: 58–62, 64, 66.
10.
DemlingR.H., DeSantiL.Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma.1997; 43: 47–51.
11.
SpungenA.M., GrimmD.R., StrakhanM.Treatment with an anabolic agent is associated with improvement in respiratory function in persons with tetraplegia: A pilot study. Mt Sinai J Med.1999; 66: 201–5.
12.
FerreiraI.M., VerreschiI.T., NeryL.E.The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest.1998; 114: 19–28.
13.
ScholsA.M., SoetersP.B., MostertR.Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: A placebo-controlled randomized trial. Am J Respir Crit Care Med.1995; 152: 1268–74.
14.
Fox-WheelerS., HellerL., SalataC.M.Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients. Pediatrics.1999; 104: 73.
15.
StrawfordA., BarbieriT., Van LoanM.Resistance exercise and supra-physiologic androgen therapy in eugo-nadal men with HIV-related weight loss: A randomized controlled trial. JAMA.1999; 281: 1282–90.
16.
SegalD.M., PerezM., ShapshakP.Oxandrolone, used for treatment of wasting disease in HIV-1-infected patients, does not diminish the antiviral activity of deoxynucleoside analogues in lymphocyte and macrophage cell cultures. J Acquir Immune Defic Syndr Hum Retrovirol.1999; 20: 215–9.
17.
BergerJ.R., PallL., HallC.D.Oxandrolone in AIDS-wasting myopathy. AIDS.1996; 10: 1657–62.
18.
JohansenK.L., MulliganK., Schambe-lanM.Anabolic effects of nandrolone decanoate in patients receiving dialysis: A randomized controlled trial. JAMA.1999; 281: 1275–81.
19.
MendenhallC.L., MoritzT.E., RoselleG.A.Protein energy malnutrition in severe alcoholic hepatitis: Diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr.1995; 19: 258–65.
20.
MendenhallC.L., MoritzT.E., RoselleG.A.A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: Results of a Department of Veterans Affairs cooperative study. Hepatology.1993; 17: 564–76.
